Solvay Q2 2025 presentation: EBITDA outlook cut amid margin pressure

Solvay SA reported a challenging Q2 2025, with organic sales declining 4% to €1.1 billion and underlying EBITDA falling 12% to €230 million, leading to margin compression. This underperformance, driven by volume and pricing pressures, particularly in its Basic Chemicals segment, prompted a significant downward revision of its full-year 2025 underlying EBITDA guidance to €880-€930 million from a previous range of €1,000-€1,100 million. Despite ongoing cost-saving efforts and a stable BBB- credit rating, net debt increased to €1.9 billion, pushing leverage to 1.9x, highlighting persistent market challenges.

Analysis

Solvay's second-quarter 2025 results reveal a significant deterioration in operating performance, prompting a substantial downward revision of its full-year guidance. The company reported a 4% year-over-year organic decline in net sales to €1.1 billion and a more pronounced 12% organic drop in underlying EBITDA to €230 million, compressing the EBITDA margin by 190 basis points to 20.9%. This underperformance was driven by a combination of a 2% decrease in volumes and a 2% decline in pricing. The weakness was concentrated in the Basic Chemicals segment, where EBITDA plunged 27% on significant pricing and cost pressures in soda ash markets. In contrast, the Performance Chemicals segment showed resilience, increasing its EBITDA by 2% despite a 10% sales decline, driven by margin expansion and 6% growth in its Special Chem business. While the structural cost-saving program delivered €55 million in H1 2025, these efforts were insufficient to offset market headwinds. The balance sheet has weakened, with net debt rising to €1.9 billion and leverage increasing to 1.9x, influenced by a €254 million dividend payment. The key development is the sharp cut in full-year EBITDA guidance to a range of €880-€930 million, a material reduction from the previous forecast in the lower half of €1,000-€1,100 million, signaling that management anticipates challenging conditions will persist.

Key Decisions for Investors

• Given the substantial downward revision to full-year EBITDA guidance, investors should anticipate negative pressure on the stock as the market reprices for a weaker earnings outlook.
• Monitor the divergent performance between the struggling Basic Chemicals segment and the more resilient Performance Chemicals segment, as the latter's ability to maintain margins is a critical factor for potential stabilization.
• Closely track free cash flow generation against the revised €300 million target, as any shortfall could further elevate the 1.9x leverage ratio and risk the stability of its BBB- credit rating.
• Recognize that while cost-saving initiatives are progressing, a turnaround is highly dependent on an improvement in external market conditions, particularly pricing and volume in the core soda ash business.